Key result
Historical methacholine testing uses SBP responses to predict electroshock therapy prognosis.
Why the study?
Does the methacholine test predict prognosis with electroshock therapy?
Does the methacholine test predict prognosis with electroshock therapy?
Answers are grounded in this paper and cite their sources.
The methacholine test was historically investigated as a predictor of prognosis for patients undergoing electroshock therapy.
Introduction In 1950 Funkenstein, Greenblatt, and Solomon 1 published their work with the epinephrine-methacholine (Mecholyl) test and its relation to prognosis with electroshock therapy (EST). In 1952 2 they further reported that prognosis could be predicted with the use of methacholine alone; i. e., those patients whose systolic blood pressure did not return to a basal level 25 minutes after injection with methacholine (a Type-6 curve) had a good prognosis with EST, as did those whom the drug produced a chill and either relieved or precipitated severe anxiety. In further work 3,4 these authors felt that the type of response was perhaps related to the secretion of epinephrine-like and arterenol-like substances—the former associated with anger in and failure to establish homeostasis, the latter with anger out and the return of the systolic blood pressure to at least the preexisting basal level. Further acceptance of the above assumption was brought
No takes yet. Share an insight, caveat, or question.
James W. Maas (1958) studied Prognosis with electroshock therapy. Methacholine (Mecholyl) test was evaluated. The methacholine test was historically proposed to predict prognosis with electroshock therapy based on systolic blood pressure responses.
Synapse has enriched 10 related papers. Consider them for comparative context: